Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair
Ketty Schwartz, Jean-Jacques Mercadier
Ketty Schwartz, Jean-Jacques Mercadier
Published September 1, 2003
Citation Information: J Clin Invest. 2003;112(5):652-654. https://doi.org/10.1172/JCI19632.
View: Text | PDF
Commentary

Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair

  • Text
  • PDF
Abstract

It has long been noted that while patients with familial hypertrophic cardiomyopathy due to cardiac troponin T (cTnT) mutations often suffer sudden cardiac death, they do not develop significant ventricular hypertrophy, suggesting that a distinct cellular mechanism apart from alterations in myocardial contractility is responsible. A new study has revealed that a single missense mutation in cTnT causes a striking disruption to energy metabolism, leading to cardiomyopathy.

Authors

Ketty Schwartz, Jean-Jacques Mercadier

×

Total citations by year

Year: 2022 2021 2019 2018 2017 2016 2011 2009 2004 Total
Citations: 1 1 1 1 1 2 1 1 1 10
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (10)

Title and authors Publication Year
Structure and Dynamics of the Flexible Cardiac Troponin T Linker Domain in a Fully Reconstituted Thin Filament.
Deranek AE, Baldo AP, Lynn ML, Schwartz SD, Tardiff JC
Biochemistry 2022
Surgery for Hypertrophic Obstructive Cardiomyopathy: Comprehensive LVOT Management beyond Septal Myectomy.
Affronti A, Pruna-Guillen R, Sandoval E, Pereda D, Alcocer J, Castellà M, Quintana E
Journal of Clinical Medicine 2021
Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems
AE Deranek, MM Klass, JC Tardiff
Pflügers Archiv - European Journal of Physiology 2019
Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes
L Wang, K Kim, S Parikh, AG Cadar, KR Bersell, H He, JR Pinto, DO Kryshtal, BC Knollmann
Journal of Molecular and Cellular Cardiology 2018
Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region.
Gangadharan B, Sunitha MS, Mukherjee S, Chowdhury RR, Haque F, Sekar N, Sowdhamini R, Spudich JA, Mercer JA
Proceedings of the National Academy of Sciences 2017
Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
MA Marques, GA de Oliveira
Frontiers in physiology 2016
TNNT1, TNNT2, and TNNT3: Isoform genes, regulation, and structure–function relationships
B Wei, JP Jin
Gene 2016
Thin Filament Mutations: Developing an Integrative Approach to a Complex Disorder
JC Tardiff, J Robbins, C Seidman, H Watkins
Circulation research 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Two Functionally Identical Modular Enhancers in Drosophila Troponin T Gene Establish the Correct Protein Levels in Different Muscle Types
JA Mas, E García-Zaragoza, M Cervera
Molecular biology of the cell 2004

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts